Genmab A/S (GE9.F)

EUR 194.65

(2.93%)

EBITDA Summary of Genmab A/S

Genmab A/S's latest annual EBITDA in 2023 was 803.45 Million EUR , down -14.34% from previous year.
Genmab A/S's latest quarterly EBITDA in 2024 Q2 was 242.95 Million EUR , up 24.6% from previous quarter.
Genmab A/S reported an annual EBITDA of 972.89 Million EUR in 2022, up 101.23% from previous year.
Genmab A/S reported an annual EBITDA of 570.92 Million EUR in 2021, down -50.13% from previous year.
Genmab A/S reported a quarterly EBITDA of 242.95 Million EUR for 2024 Q2, up 24.6% from previous quarter.
Genmab A/S reported a quarterly EBITDA of 229.67 Million EUR for 2023 Q3, up 14.54% from previous quarter.

Annual EBITDA Chart of Genmab A/S (2023 - 2016)

Historical Annual EBITDA of Genmab A/S (2023 - 2016)

Year	EBITDA	EBITDA Growth
2023	803.45 Million EUR	-14.34%
2022	972.89 Million EUR	101.23%
2021	570.92 Million EUR	-50.13%
2020	827.57 Million EUR	137.11%
2019	402.14 Million EUR	88.92%
2018	227.76 Million EUR	3.59%
2017	149.62 Million EUR	29.1%
2016	157.53 Million EUR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	107.12 Million EUR	84.35%
2024 Q2	242.95 Million EUR	24.6%
2023 Q3	229.67 Million EUR	14.54%
2023 Q2	200.51 Million EUR	242.5%
2023 FY	- EUR	-14.34%
2023 Q4	223.96 Million EUR	-2.49%
2023 Q1	58.54 Million EUR	-83.62%
2022 Q1	69.09 Million EUR	-36.48%
2022 FY	- EUR	101.23%
2022 Q4	357.32 Million EUR	38.01%
2022 Q3	258.9 Million EUR	54.87%
2022 Q2	167.17 Million EUR	141.95%
2021 FY	- EUR	-50.13%
2021 Q4	108.78 Million EUR	-9.11%
2021 Q3	119.67 Million EUR	0.0%
2020 FY	- EUR	137.11%
2019 FY	- EUR	88.92%
2018 FY	- EUR	3.59%
2017 FY	- EUR	29.1%
2016 FY	- EUR	0.0%

Peer EBITDA Comparison of Genmab A/S

Name	EBITDA	EBITDA Difference
ADV.BLOCKCHAIN AG INH ON	1.94 Million EUR	-41256.599%
Branicks Group AG	149.87 Million EUR	-436.084%
aifinyo AG	3.83 Million EUR	-20842.486%
The Platform Group AG	46.75 Million EUR	-1618.319%